Aimei Health Technology Co M&A Deal with Hera Health Solutions Inc.
Aimei Health Technology Co., Ltd (AFJK), a SPAC, has entered into a non-binding letter of intent for a business combination with Hera Health Solutions Inc., a biotechnology and medical device company. Under the proposed terms, Aimei would acquire 100% of Hera's outstanding equity in exchange for shares of the combined public company. The transaction remains subject to due diligence and the execution of a definitive agreement.
- Counterparty
- Hera Health Solutions Inc.